Healthcare News

CHIFFRES CONSOLIDÉS AU 30 JUINen millions €   20232022 restated 5Évolution 2023/2022 Chiffre d’affaires610,5616,4-1,0% Évolution à taux de change constants  +0,4% Évolution à taux de change et...

CONSOLIDATED FIGURES AS AT JUNE 30in € million   20232022 restated52023/2022 change Revenue610.5616.4-1.0% Change at constant exchange rates  +0.4% Change at constant exchange rates and...

CHERRY HILL, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of stockholders on September 28, 2023 (the...

GUILFORD, Conn., Sept. 28, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today that it has...

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facil

Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) Approved in ERT-Experienced Adults First and Only Two-Component Therapy for Eligible Adults Living with Late-onset Pompe Disease Amicus...

MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the...

DALLAS, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Spectral MD, Inc. (“SMD”), a subsidiary of Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI)...

BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 28.9.2023, klo 16:35 Korjaus: Kutsu BBS-Bioactive Bone Substitutes Oyj:n ylimääräiseen yhtiökokoukseen KORJAUS: Hallintarekisterin kautta...

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 28 September 2023 at 4.35 pm (EET) Correction: Notice to the BBS-Bioactive Bone Substitutes Plc’s Extraordinary General Meeting ...